Stay updated on Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial page.

Latest updates to the Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe history now includes a new revision entry v3.6.4 and removes the previous revision v3.6.3 from the list.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe record history now shows a revision tag updated from v3.6.2 to v3.6.3, indicating a minor software update to the page.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page history shows a software release update from v3.6.0 to v3.6.2, indicating a platform version change rather than data changes to the study record.SummaryDifference0.1%

- Check53 days agoChange DetectedAdditions show that no longer looking for participants and the record revision updated to v3.6.0; Deletion removes the previous revision v3.5.5 from the history.SummaryDifference0.4%

- Check61 days agoChange DetectedRevision tag in the page footer updated from v3.5.4 to v3.5.5, signaling a new site release version. This update is metadata-related and does not modify the study record content.SummaryDifference0.1%

- Check82 days agoChange DetectedA new Revision tag v3.5.4 appears, replacing the previous revision tag v3.5.3 as part of the site's release notes.SummaryDifference0.1%

Stay in the know with updates to Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial page.